Doses of psilocybin, provided in combination with supporting psychotherapy, was found to produce significant reductions in symptoms of major depression in a study conducted by researchers at Johns Hopkins University.
The use of MDMA-assisted psychotherapy for the treatment of PTSD could receive final approval by the FDA by 2022, Rick Doblin, PhD, of the Multidisciplinary Association for Psychedelic Studies told Psych Congress 2020 preconference attendees.
SAN DIEGO—Psilocybin-assisted psychotherapy appears to have a beneficial and lasting effect on patient mood, but possible approval of the treatment remains some time away, a researcher said at Psych Congress 2019.
There has been a history of therapists being taught that there "should" be a great separation of self in a therapy session and that self-disclosure is not appropriate. In this webinar, we will be discussing the role of self in the psychotherapeutic…